期刊文献+

结直肠癌外科治疗的国内外新进展 被引量:8

下载PDF
导出
摘要 随着科学技术的发展,结直肠癌的外科治疗手段和方法和取得了很大进展.本文就结直肠癌外科治疗新方法、新辅助治疗和靶向治疗近年来国内外进展综述如下. 一、外科治疗手段的进展 目前,结直肠癌外科治疗新方法包括经肛门内窥镜微创手术(transanal endoscopic microsurgery,TEM)、腹腔镜技术、达芬奇操作系统(da Vinci surgical system)、经自然孔道内镜外科技术(natural orifice transluminal endoscopic surgery,NOTES).
作者 刘宝华
出处 《临床外科杂志》 2012年第4期225-227,共3页 Journal of Clinical Surgery
  • 相关文献

参考文献31

  • 1Gracia Solanas JA, Ramirez Rodriguez JM, Aguilella Diago V, et al. A prospective study about functional and anatomic consequences of transanal endoscopic microsurgery [ J ]. Rev Esp Enferm Dig, 2006,98 (4) :234-240.
  • 2Buess G, Hutterer F, Theiss J, et al. A system for a transanal endoscopic rectum operation [ J ]. Chirurg, 1984,55 ( 10 ) :677-680.
  • 3刘宝华.经肛门内窥镜微创手术在直肠肿瘤切除术中的应用[J].消化外科,2006,5(5):373-376. 被引量:17
  • 4Ganai S, Kanumuri P, Rao RS, et al. Local recurrence after transanal endoscopic micresurgery for rectal polyps and early cancers [ J ]. Ann Surg 0ncol,2006,13 (4) :547-556.
  • 5Demartines N, yon Flue MO, Harder FH. Transanal endoscopic microsurgical excision of rectal tumors: indications and results [ J ]. World J Surg,2001,25 (7) :870-875.
  • 6Lezoche E, Guerrieri M, Paganini AM, et al. Long-term results in patients with T2-3 NO distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery [ J ]. Br J Surg,2005,92 (12) : 1546- 1552.
  • 7邱辉忠,林国乐,肖毅,吴斌.经肛门内镜微创手术治疗直肠肿瘤120例[J].协和医学杂志,2011,2(1):33-36. 被引量:14
  • 8夏立建,刘爱武,杨明宇,李凯.经肛门内窥镜下微创外科技术治疗直肠肿瘤120例临床经验[J].中华普外科手术学杂志(电子版),2009,3(2):28-30. 被引量:14
  • 9顾晋,杜长征.肿瘤外科的新进展[J].中国临床医生杂志,2011,39(1):72-73. 被引量:1
  • 10Colon Cancer Laparoscopic or Open Resection Study Group, Buunen M, Veldkamp R, et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long term outcome of a randomised clinical trial[ J]. Lancet Onco1,2009,10( 1 ) :44-52.

二级参考文献119

  • 1中下段直肠癌外科治疗规范(草案)[J].中华胃肠外科杂志,2005,8(1):88-90. 被引量:64
  • 2腹腔镜结肠直肠癌根治手术操作指南(2006版)[J].外科理论与实践,2006,11(5):462-464. 被引量:271
  • 3邱辉忠.经肛门内镜微创手术的临床现状[J].中国实用外科杂志,2007,27(6):446-448. 被引量:8
  • 4Hayashi Y, Widjono YW, Ohta K, et al. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues [ J ]. Pathol Int, 1994,44(2) :124 - 130.
  • 5Slattery ML, Curtin K,Anderson K,et al. Associations between dietary intake and Ki-ras mutations in colon tumors: a population based study [ J ]. Cancer Res, 2000, 60 (24) : 6935 - 6941.
  • 6Van Cutsem E, Lang I, D'Haens G, et al. KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer ( mCRC ) treated with FOLFIRI with or without cetuximab : The CRYSTAL experience[ J]. J Clin Oncol, 2008,26: a2.
  • 7Bokemeyer C, Bondarenko I, Hartmann JT, et al. KRAS status and efficacy of first-line treatment of patients with metastatic colorectal cancer (mCRC) with FOLFOX with or without cetuximab: The OPUS experience[ J]. J Clin Oncol, 2008,26: a4000.
  • 8Tejpar S, Peeters M, Humblet Y, et al. Relationship of efficacy with KRAS status (wild type versus mutant) in patients with irinotecan-refractory metastatic colorectal cancer ( mCRC), treated with irinotecan (q2w) and escalating doses of cetuximab (qlw) : The EVEREST experience ( preliminary data) [J]. J Clin Oncol, 2008,26: (Suppl) : a4001.
  • 9Amado RG, Wolf M, Peeters M, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer[ J ]. J Clin 0ncol,2008, 26 (10) : 1626 - 1634.
  • 10Gondon MS, Margolin K,Talpaz M, et al. Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer[ J]. J Clin Oncology, 200!, 19 : 843 - 850.

共引文献249

同被引文献79

  • 1周长江,江洋深,付海滨,高云飞,肖东华.低位大肠癌手术中肠镜检查的必要性和指征[J].中国误诊学杂志,2004,4(1):83-83. 被引量:2
  • 2黄宣,宋震亚,钱可大,孙爱武,张奕荫,赵振刚.肠镜在大肠癌术中的临床应用分析[J].实用肿瘤杂志,2004,19(6):516-518. 被引量:2
  • 3赵刚,肖刚,黄美雄,龙海空.腹腔镜结直肠癌根治对机体免疫状态的影响[J].中华胃肠外科杂志,2005,8(5):407-409. 被引量:41
  • 4钱峰,李强,李德川.298例直肠癌全大肠肠镜检查的价值[J].肿瘤学杂志,2007,13(2):106-107. 被引量:4
  • 5Jemal A,Siegel R,Xu J,et al.Cancer statistics 2010[J].CA Cancer J Clin,2010,60(5):277-300.
  • 6Ferlay J,Shin HR,Bray F,et al.Estimates of worldwide burden of Ca-ner in 2008[J].Int J Caneer,2010,127(12);2893-2917.
  • 7熊晓红,刘友菊.腹部手术的糖尿病患者切口感染原因分析及对策[J].中国美容医学,2012,21(z1):279-280.
  • 8Ishizuka M, Nagata H, Takagi K, et al. Clinical significance of tumor pathology for postoperative survival of patients undergoing surgery for stage IV colorectal cancer [ J ]. Anticancer Res, 2012, 32:3291-3297.
  • 9Kim YB, Jeung HC, Jeong I, et al. Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer [J]. J Radiat Res, 2013, 54:52-60.
  • 10Greuter MJ,Xu XM,Lew JB,et al. Modeling the Adenoma and Serrated Pathway to Colarectal CAncer (ASCCA) [ J]. Risk A- nal, 2014, 34:889-910.

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部